Transaction · 0001829126-26-010557

Hosseinion Warren

Hosseinion Warren, DIR, reported an open-market or private purchase at Veraxa Biotech AG involving 6024.000000 shares for an estimated $10060.08. Reported holdings after the transaction were 634692.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PDIR
VRXAVeraxa Biotech AG
Filing timeSep 29
Trade dateSep 10, 2026
Filing · SECView on SEC
InsiderProfile
% of reported position traded0.96%Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 628,668 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$1.37
Pre-filing
1mo ago1w ago +11.7%1d ago +16.1%
Returns since
7d30d90d180d1y

VRXA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
VRXA since 2026-09-29Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001829126-26-010557
Ordinary Shares
Transaction date
Sep 10, 2026
Filed Sep 29, 2026, 08:10 PM · 19d delay
Shares
6.02k sh
$1.67 per share
Estimated value
$10.0k
Computed from shares × price
Holdings after
634k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 19 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Director Buy Direct Ownership
+18score
Filing-only score

+18

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The reported securities reflect the forfeiture of 71,332 Ordinary Shares of Veraxa Biotech AG (the "Company"), par value CHF 1/113.25, for no additional consideration, in connection with the Company's…

Original filing · 0001829126-26-010557
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

VRXA